(Q33987222)

30 July 2017

1 reference

title

New perspectives in asthma treatment (English)

1 reference

30 July 2017

1 reference

Pelaia G

1

1 reference

30 July 2017

Vatrella A

2

1 reference

30 July 2017

Calabrese C

3

1 reference

30 July 2017

Mazzarella G

4

1 reference

30 July 2017

Marsico SA

5

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

55 Suppl 61

1 reference

30 July 2017

page(s)

60-66

1 reference

Efficacy and safety of inhaled corticosteroids. New developments

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

An activator of calcium-dependent potassium channels isolated from a medicinal herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Discovery & development of selective M3 antagonists for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Insight into adenosine receptor function using antisense and gene-knockout approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

NF-kappa B: a pivotal role in asthma and a new target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Signal transduction through NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

IL-10: a potential therapy for allergic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

IL-12: a key cytokine in immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Definition, function and pathophysiological significance of chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Asthma therapy for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Resolution of chronic inflammation by therapeutic induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Therapeutic potential of anti-IgE antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Genetics and pulmonary medicine 8: asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

Leukotrienes as Mediators of Airway Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

The cellular and mediator basis of asthma in relation to natural history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

Contraction of human airway smooth muscle by endothelin-1 and IRL 1620: effect of bosentan

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

Bone marrow in atopy and asthma: hematopoietic mechanisms in allergic inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

Interleukin-10 regulation in normal subjects and patients with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

Defective expression of Fas messenger RNA and Fas receptor on pulmonary T cells from patients with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

Treatment of allergic airways disease with anti-IgE

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00510.X

7 January 2021

10.1034/J.1398-9995.2000.00510.X

Identifiers

DOI

1 reference

release_vtb66fzci5fsxhewuqczztjo5m

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vtb66fzci5fsxhewuqczztjo5m

24 November 2022

mapped directly with Wikidata item

1 reference